INTRODUCTION
============

Diabetic nephropathy is associated with the greatest morbidity and mortality in IDDM^[@b1-kjim-11-2-133-6])^. Although the vast majority of diabetic patients have some degree of retinopathy, nephropathy develops in only 35 to 45% of patients with IDDM^[@b2-kjim-11-2-133-6])^, so there is probably a genetic basis for diabetic nephropathy. Previous reports of clustering of diabetic nephropathy in families also provide support for the hypothesis that genetic factors contribute to susceptibility to diabetic nephropathy^[@b3-kjim-11-2-133-6],[@b4-kjim-11-2-133-6])^.

Angiotensin I converting enzyme (ACE) is a dipeptidase, which has a key role in regulating systemic and renal circulations, activating angiotensin I into the vasoconstrictor peptide angiotensin II, and inactivating the vasodilatory peptide bradykinin^[@b5-kjim-11-2-133-6])^. The ACE gene is 21 kilobases long on the chromosome 17 and consists of 26 exons^[@b6-kjim-11-2-133-6])^. A genetic polymorphism has been described in intron 16 of the ACE gene^[@b7-kjim-11-2-133-6])^. Individuals varied as to the presence (insertion, I) or absence (deletion, D) of a 287 fragment. It has been estimated that the I/D polymorphism accounts for about 47% of the total phenotype variance of serum ACE activity in the normal Caucasian population^[@b8-kjim-11-2-133-6])^. Subjects homozygote for the deletion (DD) display the highest values and those homozygote for the insertion (II) display the lowest, with heterozygotes displaying intermediate values. An excess of the DD genotype was recently observed in subjects with myocardial infarction^[@b9-kjim-11-2-133-6])^, left ventricular hypertrophy^[@b10-kjim-11-2-133-6])^ and idiopathic dilated cardiomyopathy^[@b11-kjim-11-2-133-6])^ which suggests that a genetic polymorphism affecting ACE gene expression could be associated with susceptibility to vascular disease.

In Caucasian diabetic patients, it was reported that serum ACE activity is especially elevated in IDDM subjects with microalbuminuria^[@b12-kjim-11-2-133-6])^ and II genotype of ACE gene is a marker for reduced risk for diabetic nephropathy^[@b13-kjim-11-2-133-6])^. However, I/D allele frequency of ACE gene is known to be different between Caucasian and Oriental normal populations^[@b14-kjim-11-2-133-6],[@b15-kjim-11-2-133-6])^. The present study was performed to see whether I/D polymorphism of ACE gene is associated with diabetic nephropathy in Korean IDDM patients.

METHODS
=======

1. Subjects
-----------

The study population consisted of 59 IDDM patients who had diabetic duration for more than 5 years and 107 control subjects. IDDM subjects were divided into 2 groups according to the presence or absence of diabetic nephropathy: 1) normoalbuminuric subjects (n=28) who are IDDM patients with an albumin excretion rate (AER)\<20 ug/min and 2) nephropathy cases (n=31) who have microalbuminuria or overt proteinuria or end-stage renal disease (ESRD). Microalbuminuria was defined by urinary AER between 20--200 ug/min in the absence of permanent hypertension. Overt proteinuria was defined by 24 hour urinary protein excretion of more than 500 mg. Cases with nephropathy consisted of 9 subjects with microalbuminuria, 19 with overt proteinuria and 3 with ESRD. Diabetic retinopathy was classified by independent opthalmologists as zero, background, preproliferative, proliferative.

2. Methods
----------

DNA was extracted from peripheral blood leukocytes by the salting out method. The sequence of the sense primer and anti-sense primer were 5′-GCC CTG CAG GTG TCT GCA GC-3′ and 3′-TGC CCA TAA CAG TGC TTC ATA-5′, respectively. PCR was performed in a final volume of 40 *μ*l which contained 1.0 ug of genomic DNA, 10 pmol of each primer, 200 uM each of the. four dNTP, 1.5 mM MgCl~2~, 40 mM KCl, 10 mM Tris-HCl, pH 8.0 and 2.0 unit of Taq polymerase (Korea Biotech. Inc, Taejeon, Korea). Amplication was carried out in a thermocycler (Perkin Elmer Cetus, UK) for 35 cycles with steps of denaturation at 94°C for 1 min, annealing at 60°C for 1 min and extension at 72°C for 2 min. The PCR products were electrophoresed in 2% agarose gels, and DNA was visualized directly with ethidium bromide staining.

3. Statistical analysis
-----------------------

Values are expressed as mean±SD. The difference of allele and genotype frequencies between groups was tested by chi-square analysis. Student's unpaired t-test was used to compare group means for different parameters studied.

RESULTS
=======

The insertion/large allele (560 bp) is designated I, and the deletion/shorter allele (270 bp) is designated D. Thus, each DNA sample yielded one of three possible genotypes represented as II, ID, and DD ([Fig. 1](#f1-kjim-11-2-133-6){ref-type="fig"}). Frequencies for II, ID and DD genotypes were 23, 19 and 17 in IDDM patients, and 49, 41 and 17 in control subjects, respectively. Derived allele frequencies for I and D alleles were 55.1% and 44.9% in IDDM patients and 64.9% and 35.1% in control subjects, respectively, indicating that there was no significant difference between the two groups ([Table 1](#t1-kjim-11-2-133-6){ref-type="table"}). In IDDM patients, the subjects with proliferative diabetic retinopathy (PDR) were 11 patients. Frequencies for genotypes of ACE gene were 3, 4 and 4 in subjects with PDR and 20, 15, 13 in subjects without PDR, and derived allele frequencies for I and D alleles were 45.5% and 54.5% in subjects without PDR and 57.3% and 42.7% in subjects without PDR. There was no significant difference between subjects with or without PDR ([Table 2](#t2-kjim-11-2-133-6){ref-type="table"}).

[Talbe 3](#t3-kjim-11-2-133-6){ref-type="table"} gives the clinical characteristics of 31 IDDM cases with nephropathy and 28 IDDM subjects without nephropathy. There was no significant difference in onset age, duration of diabetes and HbAlc level. But the subjects without nephropathy showed a tendency to have a mild degree of retinopathy. Frequencies for II, ID and DD genotypes were 12, 9 and 10 in nephropathy cases and 11, 10 and 7 in cases without nephropathy, and derived allele frequencies for I and D alleles were 53.2% and 46.8% in nephropathy cases and 57.1% and 42.9% in cases without nephropathy. There was no significant difference between IDDM patient with or without nephropathy ([Table 4](#t4-kjim-11-2-133-6){ref-type="table"}).

DISCUSSION
==========

The findings of previous epidemiological and family studies suggest that diabetic nephropathy results from an interaction between metabolic abnormalities that are typical of poorly controlled IDDM and predisposing genetic factors^[@b3-kjim-11-2-133-6],[@b4-kjim-11-2-133-6])^. The nature of the genetic factors, however, has remained unknown. ACE is the component of the renin angiotensin system that catalyzes its inactive precursor angiotensin I. Angiotensin II affects vasoconstriction and sodium retention, alters kidney hemodynamics and increases systemic blood presure^[@b16-kjim-11-2-133-6])^. A likely possibilty is that the ACE variant acts as a risk factor for diabetic nephropathy by modulating renal hemodynamics without affecting systemic blood pressure, as has been hypothesized for myocardial infarction^[@b9-kjim-11-2-133-6])^. In the kidney, ACE mRNA is in endothelial, mesangial and epithelial cells^[@b6-kjim-11-2-133-6])^. Other than activating conversion of angiotensin I to angiotensin II, ACE is a component of the intrarenal kallikrein-kinin system, being an inactvatior of bradykinin^[@b16-kjim-11-2-133-6])^. These two peptides, angiotensin II and bradykinin, have opposite effects on renal circulation. Recently, Marre at al^[@b13-kjim-11-2-133-6])^ suggested that II genotype of ACE gene is a marker for reduced risk for diabetic nephropathy in white French IDDM subjects, and Doria et al^[@b17-kjim-11-2-133-6])^ reported that DNA sequence differences in the ACE gene may contribute to genetic susceptibility to diabetic nephropathy in Caucasian IDDM subjects. Because IDDM has many underlying causes that may be specific to the genetic and cultural background of the patient, racial differences in genetic and etilogical mechanisms are of interest. In the present study, no association was demonstrated, indicating that ACE gene polymorphism is not implicated in the developement of diabetic nephropathy in Korean IDDM patients. It is noteworthy that the frequency of I allele in our normal control subjects, 0.649, was higher than the previously reported values of 0.431 by Tiret et al^[@b7-kjim-11-2-133-6])^ and 0.406 by Rigat et al^[@b8-kjim-11-2-133-6])^ and was very similar to the value of 0.701 by Lee^[@b14-kjim-11-2-133-6])^ in Chinese and 0.601 by Higashimori et al^[@b15-kjim-11-2-133-6])^ in Japanese control subjects. Although these differences may be due to selection bias of normal control subjects, it is most likely to be due to ethnic difference. Contrary to the previous reports, Tarnow et al^[@b18-kjim-11-2-133-6])^ reported that I/D polymorphism of ACE gene does not act as a risk factor for the development of diabetic nephropathy in Danish IDDM subjects.

We observed that I/D polymorphism of ACE gene is not implicated in the diabetic nephropathy of Korean IDDM patients. Although our sample size is small, our result may be explained by ethnic difference. If the genetic approach has provided new insights into the pathogenesis of diabetic nephropathy, studies involoving various ethnic groups are important.
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![Examples of the 3 patterns of the ACE insertion/deletion polymrphism. Homozygotes (II) have a band of 560 pb, homozygotes (DD) have a band of 270 pb and heterozygotes (ID) have both bands. The last lane shows size marker (Hae III).](kjim-11-2-133-6f1){#f1-kjim-11-2-133-6}

###### 

Frequencies of I/D Polymorphism of ACE Gene in IDDM (n=59) and Control Subjects (n=107)

              IDDM        Controls
  ----------- ----------- ------------
  Genotypes               
  II          23(39.0%)   49(45.8%)
  ID          19(32.2%)   41(38.3%)
  DD          17(28.8%)   17(15.9%)
  Alleles                 
  I           65(55.1%)   139(64.9%)
  D           53(44.9%)   75(35.1%)

x^2^=3.90(p=0.142, 2-tailed) comparing II, ID and DD genotype frequencies

x^2^=2.72(p=0.098, 2-tailed) comparing I and D allele frequencies

###### 

Frequencies of I/D Polymorphism of ACE Gene in IDDM Patients with or without PDR

              PDR(+) (n=11)   PDR(−) (n=48)
  ----------- --------------- ---------------
  Genotypes                   
  II          3(27.2%)        20(41.7%)
  ID          4(36.4%)        15(31.2%)
  DD          4(36.4%)        13(27.1%)
  Alleles                     
  I           10(45.5%)       55(57.3%)
  D           12(54.5%)       41(42.7%)

x^2^=0.82(p=0.67, 2-tailed) comparing II, ID and DD genotype frequencies

x^2^=0.59(p=0.44, 2-tailed) comparing I and D allele frequencies

###### 

Clinical Characteristics of Study Subjects

  ------------------------------------------------------------------------------
                              Nephropathy(+)\   Nephropathy(−)\   Significance
                              (n=31)            (n=28)            
  --------------------------- ----------------- ----------------- --------------
  Sex (M/F)                   13/18             16/12             NS

  Age (yr)                    34.6±12.6         35.7±9.8          NS

  Onset age (yr)              23.7±12.0         26.0±8.8          NS

  Duration of diabetes (yr)   10.9±5.2          9.7±4.2           NS

  BMI (kg/m^2^)               19.4±2.0          18.9±2.1          NS

  Fasting C-peptide (ng/ml)   0.41±0.29         0.41±0.31         NS

  HbAlc (%)                   10.6±3.0          9.6±3.2           NS

  Retinopathy                                                     

   Zero                       5                 16                p\<0.05

   Background                 15                8                 

   Preproliferative           3                 1                 

   Prodliferative             8                 3                 
  ------------------------------------------------------------------------------

Data are mean±SD. The subjects without nephropathy showed a tendency of having a mild degree of retinopathy compared to those with nephropathy (x^2^=11.04, p\<0.05)

###### 

Frequencies of I/D Polymorphism of ACE Gene in IDDM Patients with or without Nephropathy

  -----------------------------------------------
              Nephropathy(+)\   Nephropathy(−)\
              (n=31)            (n=28)
  ----------- ----------------- -----------------
  Genotypes                     

  II          12(38.7%)         11(39.3%)

  ID          9(29.0%)          10(35.7%)

  DD          10(32.3%)         7(25.0%)

  Alleles                       

  I           33(53.2%)         32(57.1%)

  D           29(46.8%)         24(42.9%)
  -----------------------------------------------

x^2^=0.47(p=0.78, 2-tailed) comparing II, ID and DD genotype frequencies

x^2^=0.05(p=0.81, 2-tailed) comparing I and D allele frequencies
